Business News • PR NewsWire • Gnubiotics gains allowance of patent of microbiome markers for prediction, identification and treatment of pet obesity from the European Patent Office

Gnubiotics gains allowance of patent of microbiome markers for prediction, identification and treatment of pet obesity from the European Patent Office

Gnubiotics gains allowance of patent of microbiome markers for prediction, identification and treatment of pet obesity from the European Patent Office

LAUSANNE, Switzerland, May 24, 2021 /PRNewswire/ -- Gnubiotics Sciences SA (Gnubiotics), a Swiss biotech company pioneering novel microbiome targeted solutions for humans and companion animals, today announced the allowance from the European Patent Office (EPO) for its patent application...

View More : https://www.prnewswire.com:443/news-releases/gnubiotics-gains-allowance-of-patent-of-microbiome-markers-for-prediction-i...

Releted News by prnewswire

Pomerantz Law Firm Announces the Filing of a Class Action Against Provention Bio, Inc. and Certain Officers - PRVB

ZTE veröffentlicht Nachhaltigkeitsbericht 2020

Global Automotive Image Sensors Market | Europe to occupy 30% market share, faster growth expected in APAC | Technavio

Gnubiotics gains allowance of patent of microbiome markers for prediction, identification and treatment of pet obesity from the European Patent Office

Le compte officiel du département de la culture et du tourisme de la province du Shaanxi, présent en anglais sur les réseaux sociaux à l'étranger, lance l'activité hors ligne « Meet Your Shaanxi Dream, Traveling in Shaanxi »

Sempra Energy Announces Results Of Exchange Offer For Publicly Owned Shares Of IEnova